Meta-Analysis Results for Platelet-Rich Plasma Efficacy in Poor Ovarian Reserve

A meta-analysis of seven randomized controlled trials involving 422 women with poor ovarian reserve or ovarian insufficiency. The dataset contains statistical results comparing intraovarian autologous platelet-rich plasma treatment against controls, measuring outcomes like anti-Müllerian hormone, follicle-stimulating hormone, antral follicle count, and pregnancy rates. The analysis was conducted by Yuan Fang and uploaded to figshare in May 2026.

Use Cases

• Compare treatment efficacy based on changes in serum anti-Müllerian hormone (AMH) levels.
• Assess the impact on ovarian function based on antral follicle count (AFC) data.
• Evaluate the relationship between treatment and follicle-stimulating hormone (FSH) reduction.
• Analyze the statistical heterogeneity (I²) across different clinical trial outcomes.

Strengths

• Includes results from seven randomized controlled trials, a key standard for clinical evidence.
• Reports specific statistical measures like mean differences (MD) and confidence intervals for primary outcomes.
• Follows PRISMA guidelines and is registered in PROSPERO (CRD420251233432), indicating a structured review process.

Limitations

• The dataset is small at 39.3 KB, suggesting limited scope or aggregated summary data only.
• Row count and column-level documentation are unknown, which limits assessment of granular data structure.
• The description notes heterogeneity in treatment protocols and a limited number of studies, which may affect generalizability.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of randomized controlled trials sourced from PubMed, Cochrane Central, Embase, CNKI, VIP, and Wanfang.

Time Range

Literature search conducted up to November 22, 2025.

Freshness

Last updated 2026-05-12 04:19:35.